semaglutide and gastric bypass Metabolic Bariatric Surgery vs. GLP-1 Receptor Agonists for Obesity Management The Potential of Semaglutide Once-Weekly
Description
Ongoing #GLP1 -RA Trials on #ASCVD #SELECT: Semaglutide vs Placebo in Patients With Obesity and ASCVD Without DM #SOUL: Semaglutide vs Placebo in Adults With T2D With ASCVD or CKD #SURPASS-CVOT: Tirzepatide vs Dulaglutide in Patients With T2D and ASCVD #SURMOUNT-MMO:
quantity of weight loss The treatment of obesity has been transformed by the advent of highly effective, incretin-based pharmacotherapies, which can deliver weight loss of 15-25% after one year
Disclosure: I hold a bullish position in Altimmune (ALT) through call options expiring January 2027 a leveraged, directional position that profits if the stock rises
A dietitian explains whats at stake and how supplementation can help.
LeanRx offers a weight loss program based around semaglutide, when appropriate
